Dense Social Networks Inhibit HIV Disparities Among Young Gay Black Men

Article

New research helps explain why young gay black men have much higher rates of HIV despite also having much lower rates of risky behavior.

Brian Mustanski, PhD

Brian Mustanski, PhD

New research finds dense social networks play a major role in the wide HIV risk disparity between young white men who have sex with men and their black peers.

Senior author Brian Mustanski, PhD, director of Northwestern University’s Institute for Sexual and Gender Minority Health and Wellbeing, told MD Magazine® it all has to do with how “dense” a person’s social network is. Social network density is calculated by taking the total number of friends or partners reported by a person and dividing that by the total number of potential friends or partners the person could have.

“Past research has found that the higher the score (the denser the network), the more likely an individual is to have multiple sexual partners at the same time and more contact among members of the group, thus increasing their risk of acquiring HIV,” Mustanski, a professor at Northwestern’s Feinberg School of Medicine, explained.

Mustanski and colleagues used data from a longitudinal cohort study of 1015 young men (aged 16-29) in Chicago who have sex with men. The data showed young black MSM were 16 times more likely than their white peers to be infected with the virus. They had higher rates of sexually transmitted infections as a result of anal sex. They were also more likely to have denser social networks and sleep with other young black MSM.

However, the study also exposes a frustrating public health paradox. The higher rates of HIV among young black MSM persist despite the fact that the cohort is more likely to get tested regularly for HIV and less likely to engage in risky sexual behaviors.

Mustanski said one reason is a lack of frank communication.

“Although black MSM are more likely to use condoms and less likely to abuse drugs, they also are less likely to discuss their HIV status with their sexual partners and more likely to encounter sexual orientation-related stigma,” Mustanski said.

The good news is that, while dense social networks allow for more efficient transmission of HIV, they also allow for more efficient transmission of positive public health messages.

“Dense networks are also ideal for spreading information and changing behaviors, so when an effective HIV prevention measure is identified, it spreads more easily and quickly through dense networks,” he said.

He explained that, first and foremost, physisicans should discuss PrEP and condom use with their patients.

“It’s key to take judgement out of the encounter and to make it clear it isn’t about right or wrong but about knowing the facts and using them to protect yourself and your community,” Mustanski said.

Many men will stop using PrEP once they’re in a relationship, believing they are no longer at risk, Mustanski said. However, these people still should be vigilant.

“If they want to discontinue because they are in a relationship I encourage clinicians to help them think through the need to make an explicit relationship agreement with their partner and receive at least two HIV negative test results 3 months apart,” he said.

The study, “Individual and Network Factors Associated With Racial Disparities in HIV Among Young Men Who Have Sex With Men: Results From the RADAR Cohort Study,” will be published in the January 2019 edition of the Journal of Acquired Immune Deficiency Syndromes.

Related Videos
Nanette B. Silverberg, MD: Uncovering Molluscum Epidemiology
A Year of RSV Highs and Lows, with Tina Tan, MD
Ryan A. Smith, MD: RSV Risk in Patients with IBD
Cedric Rutland, MD: Exploring Immunology's Role in Molecule Development
Cedric Rutland, MD: Mechanisms Behind Immunology, Cellular Communication
Glenn S. Tillotson, PhD: Treating Immunocompromised Patients With RBX2660
Paul Feuerstadt, MD: Administering RBX2660 With a Colonoscopy
Jessica Allegretti, MD, MPH: Evaluating the First Few Months of RBX2660
Naim Alkhouri, MD: Improving NASH Diagnosis With FibroScan
© 2024 MJH Life Sciences

All rights reserved.